Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 07, 2015 8:34 AM ET


Company Overview of Foresight Biotherapeutics, Inc.

Company Overview

Foresight Biotherapeutics, Inc., a clinical-stage drug development company, develops treatments/therapies to address unmet needs in ophthalmology and otolaryngology. The company focuses on the diseases of eye and ear. Its product candidates include FST-100 for the clinical needs of microbial eradication and reduction in inflammation associated with ocular infections, as well as for adenoviral conjunctivitis; and FST-201, a topical formulation of povidone-iodine and dexamethasone for the treatment of acute otitis media. The company was incorporated in 2008 and is based in New York, New York. As of August 3, 2015, Foresight Biotherapeutics, Inc. operates as a subsidiary of Shire plc.

50 West 57th Street

15th Floor

New York, NY 10019

United States

Founded in 2008





Key Executives for Foresight Biotherapeutics, Inc.

Co-Founder and Director
Age: 42
Co-Founder and Director
Age: 52
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
Pro Pac Labs, Inc. United States
Pedinol Pharmacal, Inc. United States
Caraco Pharmaceutical Laboratories Ltd. United States
Natural Products, LLC United States
The Tapemark Company United States

Recent Private Companies Transactions

August 3, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Foresight Biotherapeutics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at